ÄÜÅÙÃ÷ »ó¼¼º¸±â
¿Ö ÀϺ»¿¡´Â Äڷγª-19 »ç·Ê°¡ °ÅÀÇ ¾ø´Â°¡ ?


¿Ö ÀϺ»¿¡´Â Äڷγª-19 »ç·Ê°¡ °ÅÀÇ ¾ø´Â°¡ ?

¿Ö ÀϺ»¿¡´Â Äڷγª-19 »ç·Ê°¡ °ÅÀÇ ¾ø´Â°¡ ?

Àú | ¾ÆÁø

Ãâ°£ÀÏ
2020-09-28
ÆÄÀÏÆ÷¸Ë
ePub
¿ë·®
11 M
Áö¿ø±â±â
PC½º¸¶Æ®ÆùÅÂºí¸´PC
ÇöȲ
½Åû °Ç¼ö : 0 °Ç
°£·« ½Åû ¸Þ¼¼Áö
ÄÜÅÙÃ÷ ¼Ò°³
¸ñÂ÷
ÇÑÁÙ¼­Æò

ÄÜÅÙÃ÷ ¼Ò°³

ÀϺ»Àº Á¶±â ³ëÃâ, Àα¸ ¹Ðµµ ¹× °í·ÉÈ­, »çȸÀû °Å¸® µÎ±â°¡ °ÅÀÇ ¾øÀ½¿¡µµ ºÒ±¸ÇÏ°í COVID-19·Î ÀÎÇÑ ³·Àº °¨¿°°ú ³·Àº »ç¸Á·üÀ» º¸°íÇÏ°í ÀÖ´Ù. ¿©±â¼­, ¿ì¸®´Â ÀÌ º¯Ä¢¿¡ ´ëÇØ ¼³¸íÇÒ ¼ö ÀÖ´Â °¡´ÉÇÑ ÀÌÀ¯¿¡ ´ëÇØ ÃßÃøÇÏ°í Åä·ÐÇÑ´Ù.
ÀϺ»ÀÌ ³ôÀº Àα¸¹Ðµµ(µµÄì 6100¸í/sqkm ÀÌ»ó, ´º¿å½Ãº¸´Ù 2.4¹è ³ôÀº Àα¸¼ö)¿Í 65¼¼ ÀÌ»ó °íÀ§Ç豺(¾à 26%)À» Â÷ÁöÇßÀ½¿¡µµ »ç½º-CoV-2 ¹ÙÀÌ·¯½º·Î ÀÎÇÑ COVID-19 °¨¿° È®ÁøÀÚ ¼ö°¡ ¿Ö ÀÌ·¸°Ô ÀûÀºÁö °ü½ÉÀÌ ¸ð¾ÆÁö°í ÀÖ´Ù(¹Ì±¹ 15% ´ëºñ ¾à 26%). ½Ì°¡Æ÷¸£¿Í È«Äá¿¡¼­´Â ½Å¼ÓÇÏ°í ¾ö°ÝÇÑ °Ë¿ª ±ÔÄ¢°ú ¿¬¶ô ÃßÀû ±â´ÉÀÌ "°î¼±À» ÆòÆòÇÏ°Ô ¸¸µå´Â"µ¥ µµ¿òÀ» ÁÖ¾ú´Ù. ±¹³»¿¡¼­´Â ´ë·®°Ë»ç¿Í ¹æ¿ªÁ¶Ä¡°¡ »õ·Î¿î »ç·Ê ¹ß»ý·üÀ» ³·Ãá °ÍÀ¸·Î º¸ÀδÙ. ±×·¯³ª ÀϺ»Àº ¾ÆÁ÷ ±¤¹üÀ§ÇÑ °Ë»ç, Á¢ÃË ÃßÀû, ¾ö°ÝÇÑ °Ë¿ª Á¶Ä¡¸¦ ÃëÇÏÁö ¾Ê°í ÀÖÀ¸¸ç, °¨¿°ÀÚÀÇ Áõ°¡À²ÀÌ ¼¼°è Æò±ÕÀÇ 10ºÐÀÇ 1¿¡ ºÒ°úÇÑ ÀúÁ¶ÇÑ °ÍÀ¸·Î º¸°í µÇ°í ÀÖ´Ù. 1ÀÎ´ç °Ë»ç °Ç¼ö°¡ ³ª¶ó ¸¶´Ù Å©°Ô ´Þ¶ó °¨¿°·üÀ» Á÷Á¢ ºñ±³Çϱâ´Â ¾î·Æ´Ù. ±×·¯³ª È£Èí±â ÁõÈıºÀ¸·Î ÀÎÇÑ »ç¸ÁÀÌ ±ÞÁõÇÑ °Íµµ ¾Æ´Ï±â ¶§¹®¿¡ ÀÌ·¯ÇÑ ³·Àº »ç¸Á·üÀ» °Ë»ç³ª º¸°í°¡ ºÎÁ·ÇÏ´Ù°í °£´ÜÈ÷ ¼³¸íÇÒ ¼ö´Â ¾ø´Ù. ±×·¸´Ù¸é ÀϺ»Àº COVID-19¸¦ ¾î¶»°Ô ó¸®ÇßÀ»±î?

¸ñÂ÷

Á¦ 1Æí Äڷγª¹ÙÀÌ·¯½º Á¤ÀÇ

1. Äڷγª¹ÙÀÌ·¯½º°¨¿°Áõ-19(Covid-19) Á¤º¸ 7
2. Äڷγª¹ÙÀÌ·¯½º ºÐ·ù ¹× Ư¼º 9
3. Äڷγª¹ÙÀÌ·¯½º ÀüÀÚÇö¹Ì°æ ÇüÅ 11
4. Äڷγª¹ÙÀÌ·¯½º ±¸Á¶ (Covid-19 Organization) 13
5. Äڷγª19: ȯ°æ¿¡ Áö¼ÓÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥±î? 19
6. Ä¡·á¹ý(Therapeutical Method) 22



Á¦ 2Æí ¿¬±¸³í¹®
Why does Japan have so few cases of COVID-19?


1. Introduction 23
2. Japanese culture is inherently suited for social distancing, and face mask use prevents viral spread. 24
3. Japanese people have reduced susceptibility due to ACE2 receptor expression. 24
4. BCG vaccine used in Japan confers protection against COVID-19. 24
5. Conclusion 25
6. References 25